BDO Wealth Advisors’s VYNE Therapeutics VYNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-278
Closed -$7K 1158
2021
Q3
$7K Hold
278
﹤0.01% 791
2021
Q2
$18K Hold
278
﹤0.01% 655
2021
Q1
$34K Hold
278
﹤0.01% 518
2020
Q4
$32K Hold
278
﹤0.01% 401
2020
Q3
$33K Buy
+278
New +$32.4K 0.01% 378

Other funds holding VYNE

BDO Wealth Advisors's VYNE Position: Q4 2021 in Review

BDO Wealth Advisors sold out of VYNE Therapeutics (VYNE) in Q4 2021, closing a stake of 278 shares — an estimated $7K sold.

BDO Wealth Advisors first reported a position in VYNE in Q3 2020 and held it in 5 quarters. The position peaked at $34K in Q1 2021. 54 funds tracked by Wall St. Rank hold VYNE as of Q4 2021.

  • BDO Wealth Advisors reported no remaining VYNE Therapeutics position as of Q4 2021 after selling out during the quarter.
  • BDO Wealth Advisors sold 278 VYNE Therapeutics shares in Q4 2021, an estimated $7K.
  • BDO Wealth Advisors first reported a position in VYNE Therapeutics in Q3 2020 and held it in 5 quarters.
  • BDO Wealth Advisors's VYNE Therapeutics position peaked at $34K in Q1 2021.
  • 54 funds tracked by Wall St. Rank held VYNE Therapeutics as of Q4 2021.

Based on BDO Wealth Advisors's 13F filing for Q4 2021, filed 11 Feb 2022.